Bileacid Malabsorption and GLP-1 Secretion

NCT03009916 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Bileacid Malabsorption

Interventions

DRUG: "cholestagel®" (Colesevelam)
DRUG: Placebos

Sponsor

University Hospital, Gentofte, Copenhagen